Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells

References

• Biffl, W.L., Moore, E.E., Moore, F.A., Peterson, V.M. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996, 224, 647–664.
   PubMed Web of Science ®Google Scholar
• Miyawaki, T., Maeda, S., Koyama, Y., Fukuoka, R., Shimada, M. Elevation of plasma interleukin-6 level is involved in postoperative fever following major oral and maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85, 146–152.
   PubMed Web of Science ®Google Scholar
• Beilin, B., Bessler, H., Mayburd, E., Smirnov, G., Dekel, A., Yardeni, I., Shavit, Y. Effects of preemptive analgesia on pain and cytokine production in the postoperative period. Anesthesiology 2003, 98, 151–155.
   PubMed Web of Science ®Google Scholar
• Laffey, J.G., Boylan, J.F., Cheng, D.C. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 2002, 97, 215–252.
   PubMed Web of Science ®Google Scholar
• Meduri, G.U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R., Leeper, K. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995, 107, 1062–1073.
   PubMed Web of Science ®Google Scholar
• Panacek, E.A., Marshall, J.C., Albertson, T.E., Johnson, D.H., Johnson, S., MacArthur, R.D., Miller, M., Barchuk, W.T., Fischkoff, S., Kaul, M., Teoh, L., Van Meter, L., Daum, L., Lemeshow, S., Hicklin, G., Doig, C.; Monoclonal Anti-TNF: a Randomized Controlled Sepsis Study Investigators. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004, 32, 2173–2182.
   PubMed Web of Science ®Google Scholar
• Rosenbloom, A.J., Pinsky, M.R., Bryant, J.L., Shin, A., Tran, T., Whiteside, T. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. JAMA 1995, 274, 58–65.
   PubMed Web of Science ®Google Scholar
• Tanabe, K., Dohi, S., Matsuno, H., Hirade, K., Kozawa, O. Midazolam stimulates vascular endothelial growth factor release in aortic smooth muscle cells: Role of the mitogen-activated protein kinase superfamily. Anesthesiology 2003, 98, 1147–1154.
   PubMed Web of Science ®Google Scholar
• Sheu, J.R., Hsiao, G., Luk, H.N., Chen, Y.W., Chen, T.L., Lee, L.W., Lin, C.H., Chou, D.S. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. Anesthesiology 2002, 96, 651–658.
   PubMed Web of Science ®Google Scholar
• Kohjitani, A., Miyawaki, T., Funahashi, M., Mitoh, Y., Matsuo, R., Shimada, M. Intravenous anesthetics inhibit nonadrenergic noncholinergic lower esophageal sphincter relaxation via nitric oxide-cyclic guanosine monophosphate pathway modulation in rabbits. Anesthesiology 2001, 95, 176–183.
   PubMed Web of Science ®Google Scholar
• Kim, S.N., Son, S.C., Lee, S.M., Kim, C.S., Yoo, D.G., Lee, S.K., Hur, G.M., Park, J.B., Jeon, B.H. Midazolam inhibits proinflammatory mediators in the lipopolysaccharide-activated macrophage. Anesthesiology 2006, 105, 105–110.
   PubMed Web of Science ®Google Scholar
• Joo, H.K., Oh, S.C., Cho, E.J., Park, K.S., Lee, J.Y., Lee, E.J., Lee, S.K., Kim, H.S., Park, J.B., Jeon, B.H. Midazolam inhibits tumor necrosis factor-α-induced endothelial activation: involvement of the peripheral benzodiazepine receptor. Anesthesiology 2009, 110, 106–112.
   PubMed Web of Science ®Google Scholar
• Miyawaki, T., Sogawa, N., Maeda, S., Kohjitani, A., Shimada, M. Effect of midazolam on interleukin-6 mRNA expression in human peripheral blood mononuclear cells in the absence of lipopolysaccharide. Cytokine 2001, 15, 320–327.
   PubMed Web of Science ®Google Scholar
• Takaono, M., Yogosawa, T., Okawa-Takatsuji, M., Aotsuka, S. Effects of intravenous anesthetics on interleukin (IL)-6 and IL-10 production by lipopolysaccharide-stimulated mononuclear cells from healthy volunteers. Acta Anaesthesiol Scand 2002, 46, 176–179.
   PubMed Web of Science ®Google Scholar
• Helmy, S.A., Al-Attiyah, R.J. The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia 2001, 56, 4–8.
   PubMed Web of Science ®Google Scholar
• Qiao, H., Sanders, R.D., Ma, D., Wu, X., Maze, M. Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care 2009, 13, R136.
   Web of Science ®Google Scholar
• Smith, W.L., Garavito, R.M., DeWitt, D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996, 271, 33157–33160.
   PubMed Web of Science ®Google Scholar
• Gilroy, D.W., Colville-Nash, P.R., Willis, D., Chivers, J., Paul-Clark, M.J., Willoughby, D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999, 5, 698–701.
   PubMed Web of Science ®Google Scholar
• Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., Uchida, K. 15-deoxy-Δ 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 2002, 277, 10459–10466.
   PubMed Web of Science ®Google Scholar
• Tegeder, I., Pfeilschifter, J., Geisslinger, G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 2001, 15, 2057–2072.
   PubMed Web of Science ®Google Scholar
• Smith, C.J., Zhang, Y., Koboldt, C.M., Muhammad, J., Zweifel, B.S., Shaffer, A., Talley, J.J., Masferrer, J.L., Seibert, K., Isakson, P.C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998, 95, 13313–13318.
   PubMed Web of Science ®Google Scholar
• Masferrer, J.L., Zweifel, B.S., Manning, P.T., Hauser, S.D., Leahy, K.M., Smith, W.G., Isakson, P.C., Seibert, K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994, 91, 3228–3232.
   PubMed Web of Science ®Google Scholar
• Crevat-Pisano, P., Dragna, S., Granthil, C., Coassolo, P., Cano, J.P., Francois, G. Plasma concentrations and pharmacokinetics of midazolam during anaesthesia. J Pharm Pharmacol 1986, 38, 578–582.
   PubMed Web of Science ®Google Scholar
• Clark, R.B. The role of PPARs in inflammation and immunity. J Leukoc Biol 2002, 71, 388–400.
   PubMed Web of Science ®Google Scholar
• Inoue, H., Tanabe, T., Umesono, K. Feedback control of cyclooxygenase-2 expression through PPARγ. J Biol Chem 2000, 275, 28028–28032.
   PubMed Web of Science ®Google Scholar
• Jiang, C., Ting, A.T., Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391, 82–86.
   PubMed Web of Science ®Google Scholar
• Haynes, D.R., Whitehouse, M.W., Vernon-Roberts, B. The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology 1992, 76, 251–257.
   PubMed Web of Science ®Google Scholar
• Noguchi, K., Endo, H., Kondo, H., Ishikawa, I. Prostaglandin F2α upregulates interleukin-6 production in human gingival fibroblasts. J Periodont Res 2001, 36, 80–87.
   PubMed Web of Science ®Google Scholar
• Tokuda, H., Kozawa, O., Harada, A., Uematsu, T. Prostaglandin D2 induces interleukin-6 synthesis via Ca2+ mobilization in osteoblasts: Regulation by protein kinase C. Prostaglandins Leukot Essent Fatty Acids 1999, 61, 189–194.
   PubMed Web of Science ®Google Scholar